Gilead Sciences to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Webcast Available Through Gilead Corporate Website
Gilead Sciences, Inc. announced that Norbert W. Bischofberger, PhD, Gilead’s Executive Vice President, R&D and Chief Scientific Officer, and Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the RBC Capital Markets 2018 Global Healthcare Conference in New York on Wednesday, February 21 at 9:00 a.m. Eastern Time.
The audio portion of the fireside chat will be accessible live through the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.
<BACK